Related Experiment Video
Updated: Jun 13, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Serological predictors for the recurrence of atrial fibrillation after electrical cardioversion
Sook Kyoung Kim1, Hui-Nam Pak, Jae Hyung Park
1Yonsei University Health System, Seoul, Korea.
Insights
Electrical cardioversion (CV) for atrial fibrillation (AF) may fail in patients with high transforming growth factor beta (TGF)-beta. Recurrence of AF after successful CV is linked to older age and low stromal cell derived factor (SDF)-1alpha levels.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Atrial fibrillation (AF) recurrence is common after electrical cardioversion (CV).
- Predictors for failed CV and post-successful CV recurrence remain unclear.
Purpose of the Study:
- To identify predictors of failed electrical cardioversion (CV).
- To investigate factors associated with atrial fibrillation (AF) recurrence after successful CV.
Main Methods:
- 81 patients with AF undergoing CV were evaluated.
- Clinical data and pre-CV serologic markers, including transforming growth factor beta (TGF)-beta and stromal cell derived factor (SDF)-1alpha, were assessed.
- Follow-up was conducted for an average of 13.1 months.
Main Results:
- 8.6% of patients experienced failed CV.
- 32.1% had late recurrence of AF (LRAF), and 27.16% had early recurrence (ERAF).
- High TGF-beta levels predicted failed CV (p=0.0260). Older age (p=0.0220) and lower SDF-1alpha levels (p=0.0105) were associated with AF recurrence.
Conclusions:
- High TGF-beta levels are a predictor of failed electrical cardioversion.
- Older age and low SDF-1alpha levels are associated with post-CV atrial fibrillation recurrence.
Background And Objectives:
Although electrical cardioversion (CV) is effective in restoring sinus rhythm (SR) in patients with atrial fibrillation (AF), AF frequently recurs in spite of antiarrhythmic medications. We investigated the predictors of failed CV and AF recurrence after successful CV.
Subjects And Methods:
In 81 patients (M:F=63:18, 59.1+/-10.5 years old) with AF who underwent CV, clinical findings and pre-CV serologic markers were evaluated.
Results:
During 13.1+/-10.6 months of follow-up, 8.6% (7/81) showed failed CV, 27.16% (22/81) showed early recurrence atrial fibrillation (ERAF; =2 weeks), 32.1% (26/81) had late recurrence atrial fibrillation (LRAF; >2 weeks), and 32.1% (26/81) remained in SR and had no recurrence (NR). Plasma levels of transforming growth factor beta (TGF)-beta were significantly higher in patients with failed CV than in those with successful CV (p=0.0260). Patients in whom AF recurred were older (60.4+/-9.0 years old vs. 55.3+/-12.5 years old, p=0.0220), and had lower plasma levels of stromal cell derived factor (SDF)-1alpha (p=0.0105). However, there were no significant differences in these parameters between ERAF patients and LRAF patients.
Conclusion:
Post-CV recurrence commonly occurs in patients aged >60 years and who have low plasma levels of SDF-1alpha. High plasma levels of TGF-beta predict failure of electrical CV.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...

